Loading...

Home
ETF
CTKB

CTKB

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

CTKB News

Cytek Biosciences (CTKB) Projects $201 Million Revenue for 2025 with Q4 Growth of 8%

Jan 12 2026NASDAQ.COM

Cytek Biosciences Reports $201 Million Revenue for 2025, Q4 Growth of 8%

Jan 12 2026Globenewswire

Cytek Biosciences Reports $201 Million Revenue for 2025, Q4 Growth of 8%

Jan 12 2026Newsfilter

Major Stocks Including Legence, Cidara Therapeutics, Avadel Pharmaceuticals, and Omeros Rise on Friday

Nov 14 2025Benzinga

TIME Names Cytek® Biosciences Among America's Growth Leaders for 2026

Nov 12 2025Newsfilter

Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead

Nov 06 2025NASDAQ.COM

Cytek® Biosciences Strengthens Efforts to Enhance Flow Cytometry Accessibility

Oct 29 2025Newsfilter

Projected 12-Month Target for SPTM by Analysts

Oct 29 2025NASDAQ.COM

Cytek® Biosciences Enhances European Operations with New Amsterdam Facility to Improve Customer Service and Foster Growth

Oct 15 2025Newsfilter

Alvotech (ALVO) Rises 8.6%: Could This Signal More Upside Ahead?

Sep 24 2025NASDAQ.COM

Cytek Biosciences Introduces Comprehensive Cell Analysis at Major Global Conferences ICCS and ESCCA

Sep 10 2025Newsfilter

Insider Purchase: Chief Financial Officer of $CTKB Buys 35,000 Shares

Jun 03 2025NASDAQ.COM

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

May 29 2025Newsfilter

DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

May 28 2025Benzinga

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

Apr 29 2025Newsfilter

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

Mar 18 2025Yahoo Finance